J&J COVID-19 vaccine in limbo as U.S. panel delays vote on resuming shots
(Reuters) -Johnson & Johnson’s COVID-19 vaccine remained in limbo on Wednesday as a U.S. health panel called for more data …
Home »
(Reuters) -Johnson & Johnson’s COVID-19 vaccine remained in limbo on Wednesday as a U.S. health panel called for more data …
MADRID (Reuters) – Spain will only give AstraZeneca’s coronavirus vaccine to people over 60 years old after European and British …
FILE PHOTO: Bottles of Russia’s “Sputnik-V” COVID-19 vaccine are seen before inoculation at a clinic in Tver, Russia, October 12, …
WASHINGTON (Reuters) – The White House welcomed Pfizer Inc’s announcement on Wednesaday that its COVID-19 vaccine was safe and effective …
FILE PHOTO: A nurse holds a tray of syringes with AstraZeneca vaccines against the coronavirus disease (COVID-19) in Huelva, Spain …
FILE PHOTO: A medical worker waits for people to test them with a free antigen quick test in a tent …
FILE PHOTO: People walk on the street in Oslo, Norway March 20, 2017. REUTERS/Lefteris KaragiannopoulosOSLO (Reuters) – Norway is experiencing …
FILE PHOTO: A vial with the AstraZeneca’s coronavirus disease (COVID-19) vaccine is pictured in Berlin, Germany, March 16, 2021. REUTERS/Hannibal …
FILE PHOTO: A senior receives the vaccine against the coronavirus disease (COVID-19) as Quebec begins vaccinations for seniors over 85 …
ROME (Reuters) – Italy’s northern region of Piedmont said on Sunday said it would temporarily suspend AstraZeneca coronavirus shots after …
FILE PHOTO: Vials of the Sputnik V (Gam-COVID-Vac) vaccine are seen at the Del-Pest Central Hospital in Budapest, Hungary, February …
OTTAWA (Reuters) – Canada’s drug regulator on Friday approved Johnson & Johnson’s COVID-19 vaccine, the fourth such shot to be …
OTTAWA (Reuters) – Canada’s drug regulator has approved Johnson & Johnson’s COVID-19 vaccine, the fourth such shot to be given …
(Reuters) – The AMR Action Fund, which was unveiled last year by more than 20 drugmakers to help struggling antibiotic …
(Reuters) – The AMR Action Fund, which was unveiled last year by more than 20 drugmakers to help struggling antibiotic …
(Reuters) – A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the …
BERLIN (Reuters) – Dermapharm aims to start making the COVID-19 vaccine from BioNTech and U.S. partner Pfizer at a second …
FILE PHOTO: The AstraZeneca logo is pictured outside the AstraZeneca office building in Brussels as part of the coronavirus disease …